Department of Neuropsychiatry, Graduate School of Medicine, Hirosaki University, Hirosaki, Japan.
Address correspondence and reprint requests to Norio Yasui-Furukori, MD, PhD, Department of Neuropsychiatry, Graduate School of Medicine, Hirosaki University, Hirosaki, 036-8562, Japan; E-mail: [email protected]
Conflicts of Interest and Source of Funding: Funded by a Grant-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Research (JSPS, 15 K19239, 15 K19710, and 15H04754) and a grant from the Hirosaki Research Institute for Neurosciences.
Norio Yasui-Furukori has received grant/research support or honoraria from and has worked with Asteras, Dainippon, Eli Lilly, GSK, Janssen-Pharma, Meiji. Mochida, MSD, Otsuka, Pfizer, Takada, and Yoshitomi. The other authors declare that they have no competing interests. The funders had no role in the study design, data collection or analysis, decision to publish, or preparation of the manuscript.
